BIA membership continues to grow by 25% each year. In today’s blog we take a closer look at the 300+ companies which make up our membership.
The BIA currently has over 300 members. Ranging from innovative start-ups and SMEs, to multi-national companies, our members are responsible for over 90% of biotech medicines currently in clinical development in the UK. To keep up to date with the latest news from our members, do check out our Member News page.
Our goal is to secure the UK’s position as a global hub and the best location for innovative research and commercialisation. The BIA brings organisations from around the UK together to network and share best practice. Click on the image below to visit our interactive map and see where our members are located, across the UK and beyond.
BIA member companies work in a number of areas, whether biotech, pharmaceutical, academic, service providers or others. The bar chart below illustrates the various business areas which our members focus on.
Those members focusing on R&D and manufacturing are working in a variety of therapeutic areas, from antibiotics to vaccines, and everything in between. The BIA’s charity of the year for 2016 is type 1 diabetes charity JDRF.New members
In 2015, 59 new members joined the BIA. To view the full list of companies within BIA membership, why not visit the BIA member directory.
For more stats on the BIA see our Year in Numbers.